What is House Rx worth?
$253.0Mlast known valuation
House Rx last raised $55.0M in its Early Stage VC (Series B) (Nov 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for House Rx
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2025 | Early Stage VC (Series B) | $55.0M | ▮ | ▮ |
How House Rx's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For House Rx, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is House Rx worth?
- House Rx's last known valuation is $253.0M.
- How much has House Rx raised?
- House Rx has raised $84.9M in total funding across 1 recorded rounds.
- When did House Rx last raise?
- House Rx last raised in Nov 2025 (Early Stage VC (Series B)), raising $55.0M.